| Page | |||
|---|---|---|---|
| Reference LAdministrative | Information | ||
| Trustees' Annual Report |
2-3 | ||
| Accountant's Report |
|||
| Statement of Financial |
Activity | ||
| Balance Sheet | |||
| Notes to the Financial | Statements | 7-12 |
| THE CHARLOTTE FRANCES MAY | FOUNDATION | ||
|---|---|---|---|
| REFERENCE 8 ADMINISTRATIVE | INFORMATION | ||
| 1. | TRUSTEES | DrJ H Davies | |
| Dr G J Connett | |||
| Mr M H Brora | |||
| 2. | CHARITY NUMBER | 288386 | |
| 3, | PRINCIPAL ADDRESS | 1"Floor | |
| Chilworth Point |
|||
| 1 Chilworth Road |
|||
| Southampton | |||
| SO167JQ | |||
| 4. | ACCOUNTANT | Rothmans LLP |
|
| Chartered Accountants |
|||
| Chilworth Point |
|||
| 1 Chilworth Road |
|||
| Southampton | |||
| SO167JQ | |||
| 5. | BANKERS | Coutts &Co | |
| 440 Strand | |||
| London | |||
| WC2R OQS | |||
| 6. | SOLICITOR | Paris Smith | |
| Number 1 London Road |
|||
| Southampton | |||
| SO152AE |
| 2023 | 2023 | 2023 | 2022 | 2022 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | ||
| E | F | K | E | E | |||
| INCOME AND ENDOWMENTS | FROM; | ||||||
| Donations and legacies |
23,800 | 23,800 | 1,550 | 1,550 | |||
| Investments | 1,529 | 1,529 | 36 | 36 | |||
| TOTAL | |||||||
| 1,529 | 23,800 | 25,329 | 36 | 1,550 | 1,586 | ||
| EXPENDITURE ON: | |||||||
| Charitable activities |
(Note 4) | 5,567 | 7,346 | 12,913 | 1,057 | 11,505 | 12,562 |
| TOTAL | |||||||
| 5,567 | 7,346 | 12,913 | 1,057 | 11,505 | 12,562 | ||
| NET INCOME/(EXPENDITURE) | (4,039) | 16,454 | 12,416 | (1,021) | (9,955) | (10,976) | |
| NET MOVEMENT | IN FUNDS | (4,039) | 16,454 | 12,416 | (1,021) | (9,955) | (10,976) |
| RECONCILIATION | OF FUNDS | ||||||
| TOTAL FUNDS | |||||||
| BROUGHT FORWARD | 123,638 | 245,326 | 368,964 | 124,659 | 255,281 | 379,940 | |
| TOTAL FUNDS | |||||||
| CARRIED FORWARD | 119,599 | 261,781 | 381,380 | 123,638 | 245,326 | 368,964 |
| 2023 | 2023 | 2023 | 2022 | |||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | Funds | Funds | |||
| Note | F | f | f | |||
| Current Asset | ||||||
| Cash at bank and | in hand | 120,164 | 263,016 | 383,180 | 370,764 | |
| Liabilities | ||||||
| Creditors: falling due within one year |
8 | (564) | (1,236) | (1,800) | (1,800) | |
| Total net assets | 119,599 | 261,781 | 381,380 | 368,964 | ||
| THE FUNDS OF | THE CHARITY | |||||
| Unrestricted fund |
119,599 | 119,599 | 123,638 | |||
| Restricted funds |
261,781 | 261,781 | 245,326 | |||
| TOTAL CHARITY | FUNDS | 119,599 | 261,781 | 381,380 | 368,964 |
| 3. DONATION |
S | AND LEGA | CIES | ||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | ||||||
| K | |||||||
| General Donations |
23,800 | 1,550 | |||||
| Total donations and |
legacies | 23,800 | 1,550 | ||||
| 4. ANALYSIS |
OF CHARITABLE ACTIVITIES | ||||||
| Research, Education | and Resourcing | Costs | Support | costs | Total | ||
| 2023 | |||||||
| Diabetic | 774 | 134 | 908 | ||||
| Bursledon House |
3,643 | 630 | 4,274 | ||||
| Paediatric Neurology |
900 | 156 | 1,056 | ||||
| Genetic Research | 386 | 67 | 453 | ||||
| Paediatric Gastroenterology | 909 | 157 | 1,067 | ||||
| Ready Steady Go | 733 | 127 | 859 | ||||
| General and Founders |
3,663 | 633 | 4,296 | ||||
| Total expenditure | on | Charitable | Activities | 11,009 | 1,904 | 12,913 | |
| 2022 | |||||||
| Cystic Fibrosis | 4,122 | 379 | 4,501 | ||||
| Diabetic | 306 | 28 | 334 | ||||
| Bursledon House |
2,084 | 191 | 2,275 | ||||
| Paediatric Long Term |
Ventilation | 900 | 83 | 983 | |||
| Ready Steady Go | 4,093 | 376 | 4,469 | ||||
| General and Founders | |||||||
| Total expenditure | on | Charitable | Activities | 11,505 | 1,057 | 12,562 |
| Governance | and | Support costs | Support costs |
Governance costs |
Total |
|---|---|---|---|---|---|
| E | |||||
| 2023 | |||||
| Administration | of | the charity | 1,899 | 1,899 | |
| Bank charges | 5 | 5 | |||
| Total expenditure | on Support Costs | 1,904 | 1,904 | ||
| 2022 | |||||
| Administration | of | the charity | 1,050 | 1,050 | |
| Bank charges | 7 | 7 | |||
| Total expenditure | on Support Costs | 1,057 | 1,057 |
| CREDITORS: Amounts falling due withi |
n one year | |
|---|---|---|
| 2023 | 2022 | |
| E | E | |
| Accruals | 1,800 | 1,800 |
| Total | 1,800 | 1,800 |
| . ANAL | YSIS OF | FUND ASSETS AND L | IABILITIES | ||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | |||
| Funds | Funds | Funds | |||
| E | E | E | |||
| 2023 | |||||
| Current | assets | ||||
| Cash at | bank and | in hand | 120,134 | 263,016 | 383,150 |
| Current | liabilities | ||||
| Creditors | and accruals | (565) | (1,235) | (1,800) | |
| 119,569 | 261,781 | 381,350 | |||
| 2022 | |||||
| Current | assets | ||||
| Cash at | bank and | in hand | 124,421 | 246,523 | 370,944 |
| Current | liabilities | ||||
| Creditors | and accruals | (603) | (1,197) | (1,800) | |
| 123,638 | 245,326 | 369,144 |
| Other direct | ||||||||
|---|---|---|---|---|---|---|---|---|
| charitable | General | |||||||
| Balance at | Donations | Investme-nt | expendit- | administra- | Balance at | |||
| 2023 | 6 April 2022 | received | income | ure | tion costs | 5April 2023 | ||
| F | ||||||||
| Cystic Fibrosis | 4,553 | 4,553 | ||||||
| Diabetic | 68,558 | (774) | 67,784 | |||||
| Neonatal | 4,724 | 4,724 | ||||||
| Paediatric | Neurology | 37,673 | (900) | 36,773 | ||||
| Bursledon | House | 47,499 | (3,643) | 43,856 | ||||
| Asthma | 3,016 | 3,016 | ||||||
| Nephrology | 33,537 | 33,537 | ||||||
| Genetic Research | 15,150 | (386) | 14,764 | |||||
| Infantile Deafness |
17,112 | 17,112 | ||||||
| Paediatric | Gastroenterology | 1,621 | (909) | 712 | ||||
| Paediatric | Long Term | Ventilation | 3,554 | 3,554 | ||||
| Society for Paediatric | Urological | |||||||
| Surgeons (SPUS) 2013 | ||||||||
| Paediatric | Sleep Fund | 856 | 856 | |||||
| Ready Steady Go | 7,473 | 23,800 | (733) | 30,540 | ||||
| Total Restricted Funds |
245,326 | 23,800 | ~7,346) | 261,781 | ||||
| Other direct | ||||||||
| charitable | General | |||||||
| Balance at | Donations | Investme-nt | expendit- | administra- | Balance at | |||
| 2022 | 6 April 2021 | received | income | ure | tion costs | 5April 2022 | ||
| E | E | F | F | |||||
| Cystic Fibrosis | 8,675 | (4, 122) | 4,553 | |||||
| Diabetic | 68,814 | 50 | (307) | 68,558 | ||||
| Neonatal | 4,724 | 4,724 | ||||||
| Paediatric | Neurology | 37,673 | 37,673 | |||||
| Bursledon | House | 49,583 | (2,084) | 47,499 | ||||
| Asthma | 3,016 | 3,016 | ||||||
| Nephrology | 33,537 | 33,537 | ||||||
| Genetic Research | 15,150 | 15,150 | ||||||
| Infantile Deafness |
17,112 | 17,112 | ||||||
| Paediatric | Gastroenterology | 1,621 | 1,621 | |||||
| Paediatric | Long Term | Ventilation | 4,454 | (900) | 3,554 | |||
| Society for Paediatric | Urological | |||||||
| Surgeons | (SPUS)2013 | |||||||
| Paediatric | Sleep Fund | 356 | 500 | 856 | ||||
| Ready Steady Go | 10,565 | 1,000 | (4,092) | 7,473 | ||||
| Total Restricted Funds |
255,281 | 1,550 | (11,505) | 245,326 |
| Other direct | ||||||||
|---|---|---|---|---|---|---|---|---|
| charitable | Gcncral | |||||||
| Balance at | Donations | Investme-nt | expendit- | administra- | Balance at | |||
| 2023 | 6 April 2022 f |
received f |
income f |
ure | tion costs f |
5 April 2023 f |
||
| Unrestricted Funds Total Unrestricted |
Funds | 123,638 123,638 |
1,529 1,529 |
(3,663) (3,663) |
(1,904) ~),964) |
119,599 119,599 |
||
| Other direct | ||||||||
| charitable | General | |||||||
| Balance at | Donations | Investme-nt | expendit- | administra- | Balance at | |||
| 2022 | 6 April 2021 f |
received f |
income f |
ure f |
tion costs f |
5 April 2022 f |
||
| Unrestricted | Funds | 124,659 | 36 | 2 | 124,697 | |||
| Total Unrestricted | Funds | 124,659 | 36 | 2 | 124,697 |